News (20)

Seagen Inc. Announces Management Changes CI
VBI Vaccines Announces Results of Annual General Meeting BU
ACHIEVE LIFE SCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
VBI Vaccines Reports First Quarter 2023 Financial Results BU
VBI Vaccines Appoints Vaughn Himes to Board of Directors BU
VBI VACCINES INC/BC : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) AQ
VBI Vaccines Inc Appoints Vaughn Himes to Board of Directors CI
ACHIEVE LIFE SCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Transcript : Achieve Life Sciences, Inc. - Shareholder/Analyst Call
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update AQ
ACHIEVE LIFE SCIENCES, INC. : Change in Directors or Principal Officers (form 8-K) AQ
Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors AQ
Achieve Life Sciences, Inc. Announces Appointment of Dr. Vaughn Himes to Board of Directors CI
Transcript : Seattle Genetics, Inc. - Shareholder/Analyst Call
Transcript : Seattle Genetics, Inc. - Special Call
Seattle Genetics : Announces Purchase of Bothell Manufacturing Facility from Bristol-Myers Squibb BU
Seattle Genetics : Announces Executive Promotions and Leadership Appointment BU
Seattle Genetics Announces Management Changes CI
Seattle Genetics Announces Senior Executive Changes CI
Seattle Genetics, Inc. : Seattle Genetics Appoints Vice President, Medical Affairs and Announces Vice President, Quality Management Promotion BU

Insiders

Picture Vaughn Himes
Vaughn Himes

Currently, Vaughn B. Himes occupies the position of Chief Technical Officer at Seagen Inc. In his past career he was Senior Vice President-Technical Operations at ZymoGenetics, Inc., Vice President-Manufacturing Operations at AmpliPhi Biosciences Corp., Vice President-Worldwide Manufacturing at Corixa Corp., Vice President-Product Development at Genovo, Inc. and Associate Director-Biological Development at Wyeth Lederle Vaccines SA. Vaughn B. Himes received an undergraduate degree from Pomona College and a doctorate from the University of Minnesota.










No results for this search